Showing results (561-570 of 6,093) with videos related to
Sort By:
Pageof 610
International Journal of Antimicrobial Agents|April 24, 2020
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in GermanyMichael Kresken, Barbara Körber-Irrgang, Miriam Korte-Berwanger, et al.International Journal of Antimicrobial Agents|April 24, 2020
Molecular diversity of chromosomal metallo-β-lactamase genes in Elizabethkingia genusRuixue Hu, Qi Zhang, Zemao GuInternational Journal of Antimicrobial Agents|May 4, 2020
Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse modelXingxing Li, Shuo Wu, Yu Du, et al.International Journal of Antimicrobial Agents|June 2, 2020
Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infectionsLouise Roer, Frank Hansen, Henrik Hasman, et al.International Journal of Antimicrobial Agents|September 26, 2002
Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strainsCaroline Quach, Karl Weiss, Dorothy Moore, et al.International Journal of Antimicrobial Agents|July 5, 2003
Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesiiI Stock, T Grueger, B WiedemannInternational Journal of Antimicrobial Agents|July 5, 2003
In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA geneJoaquim Ruiz, Francesc Marco, Josep M Sierra, et al.International Journal of Antimicrobial Agents|July 21, 2001
Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infectionsP Ball, T M File, M Twynholm, et al.International Journal of Antimicrobial Agents|July 21, 2001
GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteriaL M Deshpande, A C Gales, R N JonesInternational Journal of Antimicrobial Agents|July 21, 2001
Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella sppR Gómez-Lus, F Adrián, R del Campo, et al.Pageof 610